The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rimner Andreas, Ruffini Enrico, Cilento Vanessa, Goren Emily, Ahmad Usman, Appel Sarit, Bille Andrea, Boubia Souheil, Brambilla Cecilia, Cangir Ayten Kayi, Detterbeck Frank, Falkson Conrad, Fang Wentao, Filosso Pier Luigi, Giaccone Giuseppe, Girard Nicolas, Guerrera Francesco, Huang James, Infante Maurizio, Kim Dong Kwan, Lucchi Marco, Marino Mirella, Marom Edith M, Nicholson Andrew G, Okumura Meinoshin, Rami-Porta Ramon, Simone Charles B, Asamura Hisao, Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards, and Participating Institutions
Аннотация
METHODS: A central thymic database was collected by the Cancer Research And Biostatistics with the contribution of the major thymic associations in the world.
RESULTS: A total of 11,347 patients were collected. Submitting organizations were the following: Japanese Association for Research in the Thymus, European Society of Thoracic Surgeons, Chinese Alliance for Research in Thymoma, Korean Association for Research in the Thymus, International Thymic Malignancy Interest Group, and Réseau tumeurs THYMiques et Cancer. Additional contributions came from centers in the United States, United Kingdom, Turkey, Australia, Spain, and Italy. A total of 9147 cases were eligible for analysis. Eligible cases for analysis came from Asia and Australia (5628 cases, 61.5%), Europe (3113 cases, 34.0%), and North America (406 cases, 4.4%).
CONCLUSIONS: This report provides an overview of the database that has informed the proposals for the updated T, N, and M components and the stage groups for the ninth TNM of malignant tumors.